Airocide to be Deployed in Pakistan
Government Hospitals
Expands Global Footprint with Distribution
Now in 52 Countries
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announced that it has expanded its global distribution reach with
our distributor, M/S Novatek Pakistan being awarded as the sole
source provider of Airocide air purification systems for government
hospitals via a government tender for the KPK Province in
Pakistan.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220609005149/en/
(Graphic: Business Wire)
Applied UV’s distribution partner, M/S Novatek Pakistan has
extensive experience in dealing with the Pakistani government and
previously won a similar government tender with the installation of
657 Airocide air purification systems installed throughout the
country.
Mr. Munawwar Zahid, CEO of M/S Novatek Pakistan stated, “M/S
Novatek Pakistan is proud to be the sole distributor of the
Airocide Patented technology that was developed for NASA and is
listed as an FDA Class II Medical device allowing us to deploy it
throughout the country of Pakistan. We were selected to partner
with Airocide because we knew that their air purification solutions
are the best in the class, which have been deployed and used by
globally recognized brands throughout the world to protect against
SARS-COV-2 and other harmful air-borne pathogens even those too
small to be filtered.”
John Andrews, Applied UV’s Chief Executive Officer stated, “We
are proud to partner with M/S Novatek Pakistan and appreciate the
trust they have placed in our Airocide suite of air purification
solutions. Improving the quality of indoor air in all public indoor
places, specifically government hospitals, protecting the
facilities, staff and the patients who frequent them from dangerous
pathogens is at the center of efforts by governments globally. With
the implementation of these government guidelines and standards for
business to use to improve indoor air quality beginning, our air
purification solutions are the best-in-class tools to use as the
world’s economy begins to re-open, post pandemic. As a Company, we
are very aware of the great importance of improving the circle of
care by protecting the worlds front line healthcare providers post
this three-year pandemic. We look forward to working with M/S
Novatek, we are extremely confident that our air purification
solutions will help them achieve their stated goals.”
Mr. Zahid, further stated, “We are grateful for invaluable
business relationship we share with Applied UV and for always
standing by our side. The support, dedication, professionalism, and
hard work of each member of Applied UV team, contributed greatly to
the success of this mutual venture. Airocide is something of great
value in Pakistan due to its filter-less technology and
environment-friendly proprieties. We see a massive demand for
Airocide in the coming year. We have enjoyed a very successful
seven-year partnership and we are looking forward to many
more.”
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s Airocide® air
purification devices are research backed, clinically proven and
developed for NASA with assistance from the University of
Wisconsin. Airocide® is listed as an FDA Class II Medical device,
utilizes a proprietary photo-catalytic (PCO) bioconversion
technology that draws air into a reaction chamber that converts
damaging molds, microorganisms, dangerous airborne pathogens,
destructive VOCs, allergens, odors and biological gasses into
harmless water vapor and green carbon dioxide without producing
ozone or other harmful byproducts. Airocide® applications include
healthcare, hospitality, grocery chains, wine making facilities,
commercial real estate, schools, dental offices, post-harvest,
grocery, cannabis facilities and homes. SteriLumen’s connected
platform for Data Driven Disinfection™ applies the power of
ultraviolet light (UVC) to destroy pathogens safely, thoroughly,
and automatically, addressing the challenge of healthcare-acquired
infections ("HAIs"). Targeted for use in facilities that have high
customer turnover such as hospitals, hotels, commercial facilities,
and other public spaces, the Company’s Lumicide™ platform uses UVC
LEDs in several patented designs for infection control in and
around high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive
location.
For more information about Applied UV, Inc., and its
subsidiaries, please visit the following websites:
https://www.applieduvinc.com/
Forward-Looking Statements
The information contained herein may contain “forward-looking
statements.” Forward-looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward-looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward-looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward-looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward-looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward-looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward-looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220609005149/en/
For additional Company Information: Applied UV Inc. John
F. Andrews Applied UV Inc., CEO & Director
john.andrews@applieduvinc.com
Contact: Brett Maas, Managing Principal Hayden IR
brett@haydenir.com (646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Sep 2023 to Sep 2024